ࡱ> `!Eb湉 #'8:U@Q2xXoGB~MI74"2("qUj/\L$N76FHʩ**rJUUCEUB9T+ UUYQi땳3톒vB"bl!ݱgwzL!__.~;D`W>&2}'~m?X]AS~ų?#F`) {QgD}_.XEd/dr,݇y%BDEv98c}qWdk=96pq<0qqdn8K*G׿UCc m@ L>-;se 0" בI c;;)e"xMzV1kh#2ȧlƜ>j9 3HV ;{'|@1y׾dr}=98;ܤas vDgQ:W*d3EbL5Fo~w}6qXUx"2<=i1$2影i82<㨟I1_ LbrQˎe8l.eInQck亗{so|w46 |Q󬕳w3 3vړ~6rL}6^UR2%1vGoI[ ȋDrk!=gb>l[ʡ> >l'lj>b$ -B\;ʮt1 i9bZ"6j S2])**VA!~4+Sf/;oɭ)ᖗ[TˎEE {_=y5Íbh\xBe?t}::4Ԥ͙oN& Nř)z~x7:|<)XIn*y]4I-MR#KxU"ڪexvMR_U,D\7qU"bU[ I꫶˔"%"VURLR_U,BSh$X$dTZ;-v~vzcMώMxnP4iQÈN ˥+wke'(gկ0wL1lnlc-".oe\5ZyxҔآ[%֮hc-#`l3e)٬Щ2URo.pJ+tZ̼xr5F[_Kݭu2rs'Sxvu*R |տnyTST,OVF=u"O: ƾcINŸ1I0+`ccgM+_-K{ySwTX;51oak뽼µwXȸDZ5q0RLGµwXȸ˱5q0RLGzµwXG`,3h ):5ߊ&rKSWhV i:u-fޟ >P068lv]J@ #G:^(uŘAT[ޥ^5-ϣyF/:`Q5 k^ZOOOpVlO'ٞzvu~wSdvSdd~~ododd~~#26/"_D/"_DdFE/lMb06J6+tjMn[ mҁBE{ ~{R c[7^Z^`N0ƤO^N[vPvz*m1JPߙ =sP9yFV/F_Y=tuUѪo3b:Wa=WWګx|[",w(bNZVaMUD,$AtlMeFؚvkGȸDZ5q0RLGB".TUHu[3ݪv IƐ):5B[Rn)tf;VԵͼwpGQOF0d$WoݖZgpuu0zxiрNNV*+~'{YWvl.i>/_Q|.sW3kѲY0[3 kj|"xn?ؚʘ7]]ICWEEǚ]끍5{[S #]]ijXSkqck*a}tlQѱFZfcC̓LyG`!) jLWμo޼7߷3%G q>'Ar0:2@&7/#>Z n+ŠZ..|~۳ zU=yIg-ez-WS/9E6)\yGeTzb ^˟ݿ2E'*<գf.^=y͸6I%'$95~tC3WG>>~L#y2lOMM=3ynꌘ1kKb~׉ջ]W0漚ZvL$'{DXI$_RW4!ս=Uj1~սդH=D؞3컗KKнI;$s!?U|;!9,T}HC=mo[#x$m>ݽT…[繆hAMG(&"ѳ:z׭^h= 2,-~Qzfl zVz)=3Zh=k=rŃкšJόB Gl+T􎭷 S[;6  i g%v+g`lr۫,+~%\pT( 劖O S7I~( VRSQt! OsO -"2"t2˵WeůH?5 lj(/58sve_eC>DŽwW1|/21%AÆh6RJKW1 }/ ˋ{:&04'f_ާ8Sg((l."!1{L-]`:PnE,hDr.0VB"nSEшX6-+^`JDܠ8mZ&{Wjr[ K /jnYz[IVU[;6%&*;6%=b[إ`ݝYk~<_-yLMf_韩q{;lSrorf4zb4pHeNiwhWqZŅ֩&ZZp+[ƃ卦J֩&ZZp\"2Ub*SBTSMSxشQ锱P-tt5wltmwl[:ӁɴEK{u*tE{{k2V.d ߃Ast?B^Ǣq28^jPȴ硡ģt(˷n|s3\]sQ_ں+SI*-DU>8"Hʗ`TܦCӬ5v%CK]񸱅H ewǍ-D!nr]ᡮ6i-dWwhbzŶQGbC:qla-d|FA[A:la k]{H6m4۴5۴S},ۄYpla-ˌdăHԆG 3 `!@[>*'8U0xZMlEu6u'&6H41mBDR*RS"[6Hv+!HEHUOpɥ*P!P倊8R!dYZze~vg&^l>ϼo޼7߷c}zjEKEna s^,Yz6:ȁV&:]Ȗu☽<ڮ]aٶEYkzFOZ']kG !3|N+?: Q1_7uuj)٢MWԤlZ?Q842#؇pA{_rt`7$oЖj<>S?;YfD=M\o#@ FC7%'}O6D\l4qJ"ޏA zF{ ? SD2h 'ˠjޡFdmA%CsA亗}wFHn4~1]` L ԯb^l*CBӻ$}Rko*n.= "&lQ xt}|tqqћ(a-g$5Wva){8: +}<@_jS./_v8;&0G{|ls,md+= aFCMUN3{d8PNeK70 EܔPT=9T4qP)UN3{8PNeKipe5WA,C--k -ti\jY'4f vEjcۺL~Favpm(gmMzJGj]-,ڮSHg$ڥj9Mϑn~qiF5|[ӊW>C^=\vUj j`*D<[vlV+DU],rDU@!V*X!R!N@YRV!~Jk j#jޡV5G %C_#L \Bd!`6]!κ?Yٹ%]v/D%UI$oSIm|̶_GYfyd;Y'gS?)[e[>oeȬq=f+~!l2 yF;Ujw t'^e@i E4%"T+Thޝ'V([h(Dj=`yhe똍"NIDV~'V([ È+<#U-T[;4ii\wZt#\qK-iO˴ms' }<.S-0y`.$MfO˔m 9\I.= k޶"tzڎ}my"6 o/P 6&dxrd6zy0?zw?] "|cd=W'b(   + Document Word.Document.80.Microsoft Word DocumentDocument Word.Document.80.Microsoft Word DocumentDocument Word.Document.80.Microsoft Word DocumentDocument Word.Document.80.Microsoft Word Document/ 0DTimes New Roman(0(z[ 0 DArialNew Roman(0(z[ 0  DWingdingsRoman(0(z[ 0  C .  @n?" dd@  @@`` XP6   ,, >>HH()  $$$$2$Eb湉 #$2$|ăazU(n $2$jLW*c AA1?@8 g4LdLd@z[ 0.Hppp@ <4BdBdl 00vS ʚ;/Yl8ʚ;<4ddddl|- 0X<4!d!dl|- 0Xr0___PPT10 2___PPT9/ 0? %%LSK-One Thin Flap LASIK vs. IntraLase DRichard J. Duffey, MD Mobile, Alabama USA ASCRS 2004 New OrleansEZE 4  My Question  .Does the IntraLase FS really cut a more predictable flap for LASIK patients with fewer complications, faster visual rehabilitation and greater patient (and surgeon) satisfaction? - -Perry Binder, MD Medical Director, IntraLase6| ` ,   To Answer   One needs to compare outcomes of thin flaps cut with a mechanical microkeratome to thin flaps cut with the IntraLase laser. Almost all recent IntraLase reports are of thin flaps. 6".^>C     DemographicsCMoria LSK-One 100 micron heads (2) 100 consecutive eyes 28 F / 22 M 38 yo mean age (range 21 to 59 yrs) 92 myopic eyes / 8 hyperopic eyes Myopia mean -4.01 D (range -1.37 to -12.62) Hyperopia mean +2.69 D (+1.50 to + 3.12) Cylinder mean 0.67 D (range 0 to 2.50) Additional 7000 eyes reviewed (130 and 150 heads) DZD6Jn | IntraLase FS Data  Perry Binder, co-medical director IntraLase From study published in JCRS: Binder P. Flap dimensions created with the IntraLase FS laser. J Cataract Refract Surg 2004; 30:26-32. 34 eyes with attempted 110 micron flaps Similar demographics to the 100 eyes in this LSK-One study LJjdDDu>" L u )Flap Characteristics in These Two Studies GFlap Complications in 7000 Eyes with Moria LSK-One vs. IntraLase ClaimsHH ,% KNon-Flap Complications in 7000 Eyes with Moria LSK-One vs. IntraLase ClaimsLL,) Intraoperative Considerations QPostoperative Considerations in 7000 Eyes with Moria LSK-One vs. IntraLase ClaimsRR,/ "Visual Recovery with Moria LSK-One  Postoperatively, there were no slipped flaps, no DLK, no epithelial defects, two epithelial slides, and day one postoperative visual acuity was 20/20 or better in 76% of eyes in the series.  Miscellaneous ConsiderationsSummaryFor Thin Flaps& thickness more predictable with Moria LSK-One than FS laser Much shorter IOP rise with microkeratome Shorter visual rehabilitation time Increased efficiency in OR with Moria Decreased cost with Moria (FS Laser has $125-$250 cost per eye for disposables) ***Only IntraLase Advantage: can re-cut sooner (even same day) with FS laser if suction lost during original flap cut:vb02 D? e Thank You     ` Ot{h______` M <ff33̙3` +ffO=ff̙H7` fff3f̙` Tff33ff` 0Ky{kOz` )R{f` GiIfff̙fR` ̙|̙3f` 3ff~>?" dd@'?lFd@  nK'o`P( n?" dd@   @@``PT     o (`0p>>K0  ''(  ZB  c $D"`   6h "M }  X Click to edit Master title style!!  (  0 "; `  RClick to edit Master text styles Second level Third level Fourth level Fifth level!    S    0t "` `  h*0      0 "`   `* 0      0| "` `  `* 0    T     "`h2   s *"`h2   s *"h2   s *"@h2   s *"0`h2   s *"0h2  s *"0@h2  s *"`0h2  s *"`h2  s *"h2  s *"@h2  s *"`n2  0" h2  s *"``h2  s *"`h2  s *"@`n2  0"``h2  s *"`h2  s *"n2  0"@n2  0"`h2  s *" h2  s *"`@n2  0"@n2   0"@@h2 ! s *"`@n2 " 0"``n2 # 0"`h2 $ s *"`@h2 % s *"``h2 & s *" h2 ' s *"` H  0޽h ? 3ff~___PPT10i. s+D=' = @B + Network6 K0 5-0(((  ZB  c $D"   60 "&wf  X Click to edit Master title style!!    0|3 "wQ   [#Click to edit Master subtitle style$$    08 "` `  h*0      0; "`   `* 0      0@ "` `  `* 0    T `]   "]p h2   s *"`]h2   s *"]h2   s *"]Eh2   s *"`h2   s *"h2  s *"Eh2  s *"yh2  s *"`B h2  s *"B h2  s *"EB h2  s *"yB n2  0",B h2  s *"`u  h2  s *"u  h2  s *"u E n2  0"yu  h2  s *"`(  h2  s *"(  n2  0"( E n2  0"y(  h2  s *",(  h2  s *"` Z n2  0" Z n2   0" EZ h2 ! s *"y Z n2 " 0"`  n2 # 0"  h2 $ s *" E h2 % s *"y  h2 & s *"A  h2 ' s *"yA  `B ( s *D"H  0޽h ? 3ff~___PPT10i. s+D=' = @B +K0  0(  x  c $ Tw  x  c $TwQ   H  0޽h ? ̙33y___PPT10Y+D=' = @B +< K0 @$(  r  S ЮM }   r  S ; `  H  0޽h ? 3ff~80___PPT10.$H< K0 P$(  r  S  ɢM }   r  S ɢ; `  H  0޽h ? 3ff~80___PPT10.%k K0 `$(  r  S ΢M }   r  S ; `  H  0޽h ? 3ff~___PPT10i.JK+D=' = @B +R K0 p:(  r  S ڢM }     S pǡ; `  "h_H  0޽h ? 3ff~80___PPT10.(4 K0 33/ݘ3(  r ̘ S M }   2  ;`M ݘ #"2&; `M [ C 3 r1?k`MVNF___PPT9(  S6 " d#  @ # l1? kM T o([ ? 3 r1?k `VNF___PPT9(  S6 " d# l > # l1? kVNF___PPT9(  jVariable 30-90 Degrees8( " d#f = # l1?y VNF___PPT9(  dFixed 30 Degrees8( " d#f < # lx1?  yVNF___PPT9(  dSide Angle Cut:( " d#[ ; 3 r1?k ` VNF___PPT9(  S6 " d# i : # lp1? k VNF___PPT9(  gMinimal Variability8( " d#e 9 # l@1?y  VNF___PPT9(  c3.12 to 5.75 mm8( " d#b 8 # l1?  y VNF___PPT9(  ` Hinge Size: ( " d #[ 7 3 r1?k ` VNF___PPT9(  S6 " d# g 6 # l1? k VNF___PPT9(  eMultiple Possible8( " d#a 5 # l1?y  VNF___PPT9(  _ Fixed Nasal8 ( " d #f 4 # l($1?  y VNF___PPT9(  dHinge Location:( " d#[ 3 3 r)1?kf ` VNF___PPT9(  S6 " d# i 2 # l-1?f k VNF___PPT9(  gMinimal Variability8( " d# 1 # l\21?yf  VNF___PPT9(  Vert. flap dia. SD = 0.24 mm8( " d#$e 0 # l71? f y VNF___PPT9(  c Flap Diameter:( " d #[ / 3 rP?1?km`f VNF___PPT9(  S6 " d# _ . # l\A1?mkf VNF___PPT9(  ] Excellent8 ( " d #_ - # ldE1?ymf VNF___PPT9(  ] Excellent8 ( " d # , # l,J1? myf VNF___PPT9(  Flap Centration:( " d#  + # l Moria LSK-One (100 micron head) N= 1008? " d>#"3Q $ # ly1? ;yF>6___PPT9 _ Flap Characteristics* " d#xB D H1 ? ;`;xB E H1 ? M`MxB F H1 ? ; MxB G H1 ?`;`MxB J H1 ? `xB L H1 ?y;yxB O H1 ?;xB R H1 ?k;kMxB V H1 ? m`mxB h H1 ? f `f xB z H1 ?  ` xB  H1 ?  ` xB  H1 ?  ` xB  H1 ? `H  0޽h ? 3ff~___PPT10i.Kp%+D=' = @B ++ K0 **'j*(  r  S h{M }   )  ;`  #"*b[o; ` [ 5 3 rP]1?k`VNF___PPT9(  S6 " d# u 4 # lR1?kVNF___PPT9(  s Rare8 ( " d# 3 # l>1?yVNF___PPT9(  /0.1 % Zero in Last 3000 Eyes80( " d/#i 2 # lX1? yVNF___PPT9(  gEpithelial Defect:( " d#[ 1 3 r1?k+ `VNF___PPT9(  S6 " d#  0 # l1?+ kVNF___PPT9(  1Rare Since Only Applanation and No Shearing Force82( " d1#  / # lȣ1?y+ VNF___PPT9(  4 3 %85( " d4#h . # l1? + yVNF___PPT9(  fEpithelial Slide:( " d#[ - 3 rH1?kr `+ VNF___PPT9(  S6 " d# X , # lذ1?r k+ VNF___PPT9(  V 08( " d# + # l̷1?yr + VNF___PPT9(  2 0 in 7,000 Eyes 83( " d2#b * # l1? r y+ VNF___PPT9(  ` Buttonhole: ( " d #[ ) 3 r 1?k`r VNF___PPT9(  S6 " d# W ( # lp1?kr VNF___PPT9(  U08( " d# ' # l01?yr VNF___PPT9(  5 1 in 7,000 Eyes86( " d5#` & # l1? yr VNF___PPT9(  ^Free Cap: ( " d# % # l1?k@` T o( $ # l1?@kVNF___PPT9(  -More Common but Easily Recut at Same Setting8.( " d-# # # l81?y@VNF___PPT9(  +0.07 % Zero Last 2000 Eyes8,( " d+#y " # l1? @yF>6___PPT9  Partial_Flap* " d # [ ! 3 r1?k;`@VNF___PPT9(  S6 " d# {   # l1?;k@VNF___PPT9(  y IntraLase: ( " d #   # l1?y;@VNF___PPT9(  'Moria LSK-One (100, 130 and 150 heads) :(( " d'##l  # lp1? ;y@VNF___PPT9(  j Flap Complications:( " d#xB 6 H1 ? ;`;xB 7 H1 ? `xB 8 H1 ? ; xB 9 H1 ?`;`xB < H1 ? @`@xB > H1 ?y;yxB A H1 ?;xB D H1 ?k;kxB H H1 ? `xB Z H1 ? r `r xB l H1 ? + `+ xB ~ H1 ? `H  0޽h ? 3ff~___PPT10i.Kf*G+D=' = @B + K0 0(  x  c $ M }   x  <A ??d H  0޽h ? ̙33y___PPT10Y+D=' = @B + K0 0( ,@I@ x  c $M }   x  <A ??[ H  0޽h ? ̙33y___PPT10Y+D=' = @B + K0 0( 0 0 x  c $M }   x  <A ??_ H  0޽h ? ̙33y___PPT10Y+D=' = @B +< K0 $(  r  S !M }   r  S h"; `  H  0޽h ? 3ff~80___PPT10.&5 K0  0( 0 0  x  c $,M }   x   <A ??p H  0޽h ? ̙33y___PPT10Y+D=' = @B + K0  0(   x  c $XM }   x  c $xY; `  H  0޽h ? ̙33y___PPT10Y+D=' = @B + K0 $(  r  S aM }   r  S b; `  H  0޽h ? 3ff~___PPT10i.qI^yP+D=' = @B +B Px\klW>wrM4 iku4ND~'nnTCFkNH)Q(B*d U BH)4wc#4|3}==g|w̼uWȅt19&R"Ϧi;:@u2>7@!P1L穀J Th5^o ܵց}!˄h#P%hh֣ȤV}QN9STr3K/~)b".L'J'Znvk"4XpVbdUX\s;C3&t$oe%#4:^ 4*46;{:ngPR~4: YQ -~ǩ k}+. J'^*aup{u>^1)d t.&%Q y\Lj׻|1|Grv7|k>QePCKJa|/R\Bۃy 䐟O ;: 'oqt#'BQDS ղ<Ӳf^}a^؜֜v7Q|;gh>Z2W^M7JG|:jP/O }Nt~J'%s MꑯDG 4t1[ɏ^T}sf)}YQ(Equ#Nkp|4:;ujsȠ_#||/uB E'H9\JD:"I0nkBO&1ka@kH sGU870{" dh8`jn2{Ĩ;Eb&[sjDSH,vfT 3[IaNFScV,*K&RcF*;a%#bPXq;σvP tt ]Ь>˟CGF^~=,Pt/a72zYneR'/ pk*k12~w)/Ew(NV}kr4n^XE:_o'~w-uQ>R@6,w1UW7_!"xs8|u.УA\98Z_rrx!22< |6KAy fwH"5N{CB^+%sUh>e簋弸,_OO_9=gtzkJЦi2{tj]yqF92pM+gc)n/|??Pw~94) +lj!uk$eO,! |/ _#uTlduB5楃-D2Nu uߘ!C&evXp< R~V_i_o,[c~B}˟JaM=2WFQmfjzJ23o턯j|aw" Zm۳݅v>v{ffgfߎʏ] $7ͤ -Oh(&rL*Sn)tC&/*V2WV!@wJ@ \ 8hnz'tom ڤ8G1dR+Ei*s*&;{xd}+'tQB9LGD=갖zɢ 6eI>]~E )<&퓯D"WQV+eU1ܶIj_Qq1ya]݈Zlb:"7?}1Ao!(x(] !9>7 dofg@Z*Ur8wHbm6{ةﹴ6/5='kmX l@Wb"ZbJC{}_E_g%PYzс[(S&x!!2Sx*zٸNdė m>D,r-ED?CS KԂTZن^?rwBv\՗Ngg\ϔ.)Zޙ\g۾g狒۪ǓG^,irvfMƭx(n%Ó!%M27[枞U]ѐvf!9XaY 7nEcD,5f`(4{ؘet=?rJyb` Jhh2gkl ")P"fTPUѴA4FA#Gp+6pthSlQ ƒ9y& ͡`]cNm&7[&IcT֛=Ac56?9X2~wA5:Vw@ݠI@?+vz~+dܒp5j+ZA]ica qv5]҉3eUlāsma[!T#d]'`i^|g56v~ٷdg{r;n<86_fUm~( ;g[P}Ѝ KZ^sի|ɧ|Pޢot|'_AwnA\<&e8yE6%ii@tpxYh9}:x's{3Iʪtɳ6O^xhIt }'yΣ/.6A͠r3s<=Ӿ,3X!b)n ҕ^g_3|()7IԾK A/kRg<1O좿LlqP7B:k$yvSB7~\(>ԟhYYgg,`,&yڶ/,[c5H)mo{ o2gN\sxZ}tȟJ8p8pF»KnQ{R\쑫6neK8oy◾+()Z[4qĥCۯҺ ˋҽd$4+zEZ7g6h;uz#dۣZvVԀ_oƓԈXm!ֈA,@;h~#Teїٳ8p8pk~ Rx\klW>wk'N؍8!d׉jqc{loXqB҈G~#!%*hQ *E *"D+Z"G@ ;sko$i[{ι9s{Xsri&]NeYqBJ" Ϥi7:@KT2>@!P9ts7erН*@+@+A*jՀ}To-@@A@<]M:E(7Aܥ`fxWer#'{߿~w1qYlTOdShm2hdadUXBs;9XhI:vE*AsG!!0rr}^# +iԤ=L׻-ty>8s/5Rz| ;yZ nan;Z2 e`%@{M$ZMħX? (vq&gA:QV'Z7 zZjYN)_9v?:WvEQjŸ;σ4v;\.sҩãtPxq|:rOFVtz#G47> S=a5_6!ԅ0;hE|E 9ee e_@ CN8l!딄;BԢS eA:5hd$4.\Gr_P:5st7m.B{wwz!Kd8u )jYJ>}i9n0u,5-rZۭWo}}ӭʬ#>=W>sp [bN&*שy& jF=> Ohel:'AlpQ1rozQul]Zcqpib c9+Y9еIWt[07XD1/2tW{g{QMBtoyqS^,ּQ48±'.AǺ1:o-5 )VMAlnu9U}y,cqqب?&TƎ( hw_Oyă¡Etz~q3*4V}FX/_B~r+~ ]Kuk*FB u 2x}Půpnsù[o֓XX~ZsCws˗ۡSkߓObc1o vuFtyZI:h& ;zw[dt uYw7u}ccCæ-0:i17ǵh<:i1+LD:gI5UEgtNj#rraGLԶ7u aG>͈ww{A(*L؎XJ̈́5-H*4ɹ ˟&tP˔n$m??f6F-A'A_t }('_/!B?͡4R'k,@'@_/aWxe($[᷊/sm KXU'|_v[>:ACXNG}˿SUE*;JE4ҼW2 ?77/_'w?͙+=(`R7GZ>w!dzfUR]$?ʱ˼𷂲 JA>b<_tU9e);;sjcQ,>zSW6p@J;_Cw9!מ i@!XZo_陨މ638I O3}tlb/N|/$ _&yRkF!mdMB5n^!SB7~LH ;rUIgVoUjnH_]z4H+#+؂<;oN|ePU-B738!s,x_P\RJ{8K4~%׮rISTx-VfJ聨33Ug\xsV%C*~i=~jϣmpAmNMԈڌYFvێ07#}lA}=ZZmA&=͠eɲ T M pq\dJMҌ).*ɘ;!J>(ȹE[LGqr 2 l}-N4H6/k *S!ֿ?ISht`E$< œ pgAmhpOl$ܱ5&GNwdzI3q^zm ]OryEr v݈N^{n؇Vz>%BX#`H6p)0OF)]dI=APZTmB6G R-˖jB!(FR{ۻ >c4:^4.S4Ѓw8?Z:nNI:)(4: YS-~3u> #?@OeYUAa9HbŅd]: nR,Ď9Xԥwy16rp~GP;5EiБR @\?5vSh#kpJiOPj Ьy&N?|"ْR1-Poիki} ŷre1sN_L[!2 fI0u1OɏT}ٸMJ$b(qu+Nk/x' it8u̶o|QIDL t<߅˳_!"dqU]BV-Ni˗(2g euC{QIBSo+wBHhQ'ccO^=CҺ1dgWjP lr,uR.f<6oq]-@~%?^x>NlR)걆8~⽡)TJ=Zs,ڜ~9Wr=>BvWPʈ~J4MnEڐ֕ppoQ+zy򼰿=| ([~~~]titbQk=NWV95l}vXjĉN7:I;q18Rӗpuu;Au]tSi3iuIk`qL-#S~'9aOX²)BY(eOOX5tO#t1kPtIYcqL\ؼl D,1nuL'O:֘㎛0',&D;TZJvF&nĨci'a'P{JCMշA`}O9:_3Q;ԛ5N΂eװlv+^Y%ɶrTg C8V "8 7 ͍YoSd-6n76/ggrォ]\\9HaU#q%Їj8XX'A{@+@ӔnX-$,2!!6ڟ,oQ^W.^J)Of>C0rͻM$֒sl{Cb^\Q氯B.a j3{GWm5;Q CA&ō a0SM\7߽7QsQz?=̎ uϒp|M;naˤbKSԝ᫤ ux~.ImB7>,q_Ə %M*o?uvvMg@\m)?ekEq[no䡧/ߚxU}oO뻯BWvSU)@ @LKnvoɅ޿rBq;_17~?(=K3|q;݆l5Sl@O,)ї@!<)ێ¦e6m@/k޿Ŷ[&!zvvmO9Q2HZέ*_UO tc3zEZ6G[ulzCtu׺n/3:A;j).Dk@.;l5"qn @ @ 7rrh KX@I Pj{6RW͌@wURNP{? &pOh+'0 hp    ,4Why Not IntraLase FS Now?iRichard J. Duffy, M.D.wClouds Damien GUERINfy13iMicrosoft PowerPoint.w@6Ex"@N.@oGng  / '  x-- @ !x--'--%:0--'3f--&$--'--&$--'--&$--'--&$--'--&$--'--&$--'f--&$--'3f--&$--'--&$--'f--&$--'--&$--'--&$--'3f--&$--'f--&$--'--&$--'--&$--'f--&$--'--&$--'--&$--'--&$--'--&$--'f--&$--'--&$--'--&$--'--&$--'--&$     --'--&$     --'--&$     --'--&$     --'--&$--'--&$--'--%--'@Arial-. 3f 2 NSLSK."Systemdi-@Arial-. 3f 2 N- .-@Arial-. 3f2 NOne Thin Flap      .-@Arial-. 3f2 vG LASIK vs.    .-@Arial-. 3f2 v IntraLase  .-@Arial-. 2 Richard J. a   .-@Arial-. 2 Duffey  .-@Arial-.  2 W, MD.-@Arial-. '2 Mobile, Alabama USA     .-@Arial-. 2  ASCRS 2004a   .-@Arial-. 2 ! New Orleansa  .-՜.+,0     Affichage l'cran finA Times New RomanArial WingdingsNetworkMicrosoft Word Document&LSK-One Thin Flap LASIK vs. IntraLase My Question To Answer DemographicsIntraLase FS Data*Flap Characteristics in These Two StudiesHFlap Complications in 7000 Eyes with Moria LSK-One vs. IntraLase ClaimsLNon-Flap Complications in 7000 Eyes with Moria LSK-One vs. IntraLase ClaimsIntraoperative ConsiderationsRPostoperative Considerations in 7000 Eyes with Moria LSK-One vs. IntraLase Claims#Visual Recovery with Moria LSK-OneMiscellaneous ConsiderationsSummary Thank You Polices utilisesModle de conceptionServeurs OLE incorporsTitres des diapositives%_ Damien GUERINDamien GUERIN  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root EntrydO)Pictures#Current UserSummaryInformation(PowerPoint Document(DocumentSummaryInformation8Root EntrydO)@^Pictures#Current UserGSummaryInformation(%_ Wonder ArtistWonder Artist